查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1516928

活细胞成像的全球市场的评估:各类产品·服务，各技术，各用途，各终端用户，各地区，机会，预测，2017年～2031年

Live Cell Imaging Market Assessment, By Products and Services, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 230 Pages | 商品交期: 3-5个工作天内

价格

根据预测，全球活细胞成像市场规模将从 2023 年的 25.5 亿美元成长到 2031 年的 46.1 亿美元，2024-2031 年预测期间复合年增长率为 7.68%。该市场的成长是由细胞生物学研究活动的增加、慢性疾病的增加、活细胞成像技术的进步以及市场主要参与者开发新技术和产品的努力所推动的。

癌症和神经退化性疾病等慢性疾病的增加是推动市场需求的主要因素之一。活细胞成像提供形态、空间和分子数据，帮助更好地了解决定癌症对治疗反应的信号传导和细胞事件。这些资讯有可能确定可操作的目标和生物标记物，有助于改善临床结果。活细胞成像也可用于阐明抗癌药物的作用机制和肿瘤对治疗的异质性。

加强各公司之间的联合研究也是支持市场扩张的主要因素。 2023年2月，上海多宁生物科技有限公司获得BioAces上海生命科学细胞分析产品组合的独家授权，包括CytScop MINI和CytScop PRO。 BioAces的产品包括流式细胞仪、高内涵分析仪器和即时动态活细胞成像系统，用于细胞和基因治疗、疫苗、单株抗体等上游製程开发。

本报告提供全球活细胞成像市场相关调查，提供市场概要，以及各类产品·服务，各技术，各用途，各终端用户，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 调查手法

第2章 计划的范围和定义

第3章 摘要整理

第4章 全球活细胞成像市场预测，2017年～2031年

  • 市场规模与预测
  • 各类产品·服务
  • 各技术
  • 各用途
  • 各终端用户
  • 各地区
  • 各企业市场占有率(%)、2023年

第5章 全球活细胞成像市场预测，各地区，2017年～2031年

  • 北美
  • 欧洲
  • 亚太地区
  • 中东·非洲

第6章 市场製图，2023年

第7章 宏观环境和产业结构

  • 供给需求分析
  • 进出口分析
  • 价值链分析
  • PESTEL分析
  • 波特的五力分析

第8章 市场动态

第9章 法规结构和革新

第10章 主要加入企业的形势

第11章 价格分析

第12章 案例研究

第13章 主要加入企业预测

  • Thermo Fisher Scientific Inc.
  • PerkinElmer, Inc.
  • Merck & Co., Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • NIKON CORPORATION
  • Olympus Corporation
  • Carl Zeiss AG
  • Sartorius AG

第14章 策略性建议

第15章 咨询方式和免责声明

Product Code: MX11613

Global live cell imaging market is projected to witness a CAGR of 7.68% during the forecast period 2024-2031, growing from USD 2.55 billion in 2023 to USD 4.61 billion in 2031. The market's growth is boosted by augmenting research activities in cell biology, rising cases of chronic diseases, technological advancements in live cell imaging, and increasing efforts toward the development of novel technologies and products by the key players in the market.

The increasing incidences of chronic diseases such as cancer and neurodegenerative disorders are one of the major factors bolstering the market demand. Live cell imaging provides morphological, spatial, and molecular data that aids in providing a deeper understanding of the signaling and cellular events that determine the response of the cancer to the treatment. This information has the potential to identify actionable targets and biomarkers that can aid in enhancing clinical outcomes. Live cell imaging also finds applications in uncovering the mode of action of cancer drugs and tumor heterogeneity in response to the treatment.

Rising collaborations between various companies are another major factor supporting the market's expansion. In February 2023, Shanghai Duoning Biotechnology Co., Ltd. obtained an exclusive license for BioAces Shanghai Life Science's cell analysis portfolio, including the CytScop MINI and CytScop PRO. The products provided by BioAces include flow cytometry instrument, high content analysis equipment, and real-time dynamic live cell imaging system that find applications in upstream process development of cell and gene therapies, vaccines, and monoclonal antibodies, among others.

Technological Advancements Boost Market Growth

Continuous technological advancements in imaging technology are expected to support the growth of the global live cell imaging market. Various biotechnology and imaging companies are increasingly investing towards developing advanced technological solutions to aid scientists and researchers in conducting live cell imaging at the nanoscale. For instance, in March 2024, Leica Microsystems GmbH unveiled TauSTED Xtend, the super-resolution platform that aids researchers in directly monitoring fast biological processes and allows for multicolor live cell imaging at the nanoscale. It also aids in ensuring that live cell experiments are monitored over a longer period of time with the help of a balance of resolution and light exposure. The company aims to ensure that TauSTED can be easily incorporated into laboratory workflow and support physicians in enhancing their preferred imaging protocols with stimulated emission depletion (STED). Such developments are expected to provide lucrative growth opportunities for the market and boost its expansion in the coming years.

Increasing Cases of Chronic Diseases Support Market Expansion

The rising cases of various chronic diseases across the globe are propelling the demand for live cell imaging in the global market. According to the estimates of the National Cancer Institute, 9.7 million deaths and 20 million new cases of cancer were reported in 2022 and by 2040, the number of cancer-related deaths is projected to increase to 15.3 million and new cancer cases to 29.9 million. This growth is bolstering the investments towards cancer research, which in turn is propelling the requirement in live cell imaging as it plays a crucial role in enhancing the understanding of the mechanism of the disease and for studying the efforts of the immune system in fighting cancer cells.

Moreover, live cell imaging also plays a crucial role in studying central nervous system (CNS) diseases, offering insights into the disease biology and consequences of behavioral therapy and pharmacological and genetic interventions in real time. Live cell imaging also aids scientists in detecting synaptic dysfunctions at an earlier stage. Thus, due to the growing burden of CNS diseases and disorders, the requirement for live cell imaging is increasing, supporting the growth of the market.

Asia-Pacific is Anticipated to Witness Significant Growth

The rapid expansion of the market in the region is supported by the growth of the healthcare sector due to rising cases of chronic diseases and disorders and increasing geriatric population, rising awareness about the various applications and advantages associated with the technology, and growing investments in life science research. The growing popularity of regenerative medicine in the region also propels the requirement for live cell imaging. The multidisciplinary field involves the development of biological substitutes that aid in maintaining, improving, and restoring the functions of the body.

Additionally, the increasing efforts of the companies and institutes based in the region towards the development and introduction of novel products and technologies are also aiding the market's growth in Asia-Pacific. In April 2024, Yokogawa Electric Corporation, headquartered in Japan, announced its Single Cellome System SS2000, which was featured in the Analytical Chemistry journal. The device features Yokogawa's dual-microlens spinning disk imaging technology that aids researchers in conducting cutting-edge life science research and uses confocal imaging technology to eliminate the different challenges associated with single-cell lipidomics. Such developments are expected to bolster the growth of the market in different regions across the Asia-Pacific.

Standalone Systems Expected to Hold Significant Market Share

These devices and equipment are capable of functioning independently and are witnessing an increased demand due to the growing emphasis on research and development activities. Additionally, rising collaborations between different research institutions and imaging companies are bolstering the expansion of the segment. In February 2022, Deepcell, Inc. announced a partnership with the Translational Genomics Research Institute (TGen). The former is involved with the development of a novel imaging platform that analyzes individual live cells with the help of artificial intelligence in real time. This technology is expected to aid scientists in isolating, characterizing, and identifying viable cells and utilize sorted cells and artificial intelligence-derived markers to complement novel standalone methods and existing molecular workflows. Furthermore, the different product offerings by leading market players, including the stand-alone BD Pathway 855 by Becton, Dickinson and Company, provide various advantages, including ease of use, which in turn aids in enhancing productivity and improving workflow. It also features precision optics with flexible controls and a confocal mode that enables the delivery of high-resolution images.

Future Market Scenario (2024-2031F)

As per the global live cell imaging market analysis, the integration of machine learning and artificial intelligence (AI) with live cell imaging is expected to provide lucrative growth opportunities to the market in the coming years. With the help of AI algorithms, researchers can automate tasks associated with image analysis, process large sets of data, and identify patterns that will allow them to retrieve meaningful insights, enhancing disease research and drug development processes.

Additionally, the rising cases of chronic diseases are anticipated to positively influence the market's expansion due to the various applications of the technique in understanding the mechanism of the diseases and in drug development processes.

Computational methods are expected to aid in addressing various challenges associated with live cell imaging, including the capture of intra-cellular dynamics while ensuring the viability of the cell. The methods focused on AI-based approaches can be layered on hybrid methods and existing microscopies that allow the integration of microscope hardware and computation. Computational approaches are also expected to aid in improving temporal and spatial resolution and signal-to-noise ratio of live cell imaging.

Key Players Landscape and Outlook

Novel product launches by the key market players are boosting the global live cell imaging market size. In June 2024, NIKON CORPORATION introduced the new imaging technology to accelerate the efficiency and speed of biotechnology research. With the introduction of the AXR with NSPARC 2K, the company is expanding its AX series lineup to boost efficiency across drug development and disease research. The Nikon Spatial Array Confocal (NSPARC) detector allows for precise observations and shares image contrast and low noise, while the newly updated software provides an increased observation range. Such developments aid in enhancing the understanding of complex diseases such as Alzheimer's disease and cancer while assisting researchers in their drug development efforts. The new technology will also allow researchers to track the growth process of tissues and cells within disease models, allowing the assessment of the safety and efficacy of new therapies.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Live Cell Imaging Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Products and Services
    • 4.2.1. Instruments
      • 4.2.1.1. Cell Analyzers
      • 4.2.1.2. Accessories
      • 4.2.1.3. Microscopes
      • 4.2.1.4. Standalone Systems
    • 4.2.2. Consumables
      • 4.2.2.1. Reagents
      • 4.2.2.2. Media
      • 4.2.2.3. Assay Kits
      • 4.2.2.4. Others
    • 4.2.3. Services
    • 4.2.4. Software
  • 4.3. By Technology
    • 4.3.1. High Content Screening (HCS)
    • 4.3.2. Fluorescence Resonance Energy Transfer (FRET)
    • 4.3.3. Fluorescence Recovery After Photobleaching (FRAP)
    • 4.3.4. Time-lapse Microscopy
    • 4.3.5. Others
  • 4.4. By Application
    • 4.4.1. Cell Biology
    • 4.4.2. Stem Cells
    • 4.4.3. Developmental Biology
    • 4.4.4. Drug Discovery
  • 4.5. By End-user
    • 4.5.1. Pharmaceutical and Biotechnological Companies
    • 4.5.2. Academic and Research Institutes
    • 4.5.3. Contract Research Organizations
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. South America
    • 4.6.3. Europe
    • 4.6.4. Asia-Pacific
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Live Cell Imaging Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Products and Services
      • 5.1.2.1. Instruments
        • 5.1.2.1.1. Cell Analyzers
        • 5.1.2.1.2. Accessories
        • 5.1.2.1.3. Microscopes
        • 5.1.2.1.4. Standalone Systems
      • 5.1.2.2. Consumables
        • 5.1.2.2.1. Reagents
        • 5.1.2.2.2. Media
        • 5.1.2.2.3. Assay Kits
        • 5.1.2.2.4. Others
      • 5.1.2.3. Services
      • 5.1.2.4. Software
    • 5.1.3. By Technology
      • 5.1.3.1. High Content Screening (HCS)
      • 5.1.3.2. Fluorescence Resonance Energy Transfer (FRET)
      • 5.1.3.3. Fluorescence Recovery After Photobleaching (FRAP)
      • 5.1.3.4. Time-lapse Microscopy
      • 5.1.3.5. Others
    • 5.1.4. By Application
      • 5.1.4.1. Cell Biology
      • 5.1.4.2. Stem Cells
      • 5.1.4.3. Developmental Biology
      • 5.1.4.4. Drug Discovery
    • 5.1.5. By End-user
      • 5.1.5.1. Pharmaceutical and Biotechnological Companies
      • 5.1.5.2. Academic and Research Institutes
      • 5.1.5.3. Contract Research Organizations
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
        • 5.1.6.1.1. By Value
        • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Products and Services
        • 5.1.6.2.1. Instruments
          • 5.1.6.2.1.1. Cell Analyzers
          • 5.1.6.2.1.2. Accessories
          • 5.1.6.2.1.3. Microscopes
          • 5.1.6.2.1.4. Standalone Systems
        • 5.1.6.2.2. Consumables
          • 5.1.6.2.2.1. Reagents
          • 5.1.6.2.2.2. Media
          • 5.1.6.2.2.3. Assay Kits
          • 5.1.6.2.2.4. Others
        • 5.1.6.2.3. Services
        • 5.1.6.2.4. Software
      • 5.1.6.3. By Technology
        • 5.1.6.3.1. High Content Screening (HCS)
        • 5.1.6.3.2. Fluorescence Resonance Energy Transfer (FRET)
        • 5.1.6.3.3. Fluorescence Recovery After Photobleaching (FRAP)
        • 5.1.6.3.4. Time-lapse Microscopy
        • 5.1.6.3.5. Others
      • 5.1.6.4. By Application
        • 5.1.6.4.1. Cell Biology
        • 5.1.6.4.2. Stem Cells
        • 5.1.6.4.3. Developmental Biology
        • 5.1.6.4.4. Drug Discovery
      • 5.1.6.5. By End-user
        • 5.1.6.5.1. Pharmaceutical and Biotechnological Companies
        • 5.1.6.5.2. Academic and Research Institutes
        • 5.1.6.5.3. Contract Research Organizations
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Products and Services
  • 6.2. By Technology
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. PerkinElmer, Inc.
  • 13.3. Merck & Co., Inc.
  • 13.4. Agilent Technologies, Inc.
  • 13.5. Becton, Dickinson and Company
  • 13.6. Danaher Corporation
  • 13.7. NIKON CORPORATION
  • 13.8. Olympus Corporation
  • 13.9. Carl Zeiss AG
  • 13.10. Sartorius AG

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 4. Global Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Live Cell Imaging Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 11. North America Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 12. North America Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Live Cell Imaging Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 18. United States Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 19. United States Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 24. Canada Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 25. Canada Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 30. Mexico Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 31. Mexico Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 36. Europe Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 37. Europe Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Live Cell Imaging Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 43. Germany Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 44. Germany Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 49. France Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 50. France Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 51. France Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 55. Italy Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 56. Italy Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 61. United Kingdom Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 62. United Kingdom Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 67. Russia Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 68. Russia Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 73. Netherlands Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 74. Netherlands Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 79. Spain Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 80. Spain Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 85. Turkey Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 86. Turkey Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 91. Poland Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 92. Poland Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 97. South America Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 98. South America Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Live Cell Imaging Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 104. Brazil Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 105. Brazil Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 110. Argentina Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 111. Argentina Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 116. Asia-Pacific Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 117. Asia-Pacific Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Live Cell Imaging Market Share (%), By Country, 2017-2031F
  • Figure 120. India Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 123. India Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 124. India Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 125. India Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 129. China Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 130. China Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 131. China Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 135. Japan Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 136. Japan Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 141. Australia Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 142. Australia Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 147. Vietnam Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 148. Vietnam Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 153. South Korea Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 154. South Korea Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 159. Indonesia Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 160. Indonesia Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 165. Philippines Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 166. Philippines Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 171. Middle East & Africa Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 172. Middle East & Africa Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Live Cell Imaging Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 178. Saudi Arabia Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 179. Saudi Arabia Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 184. UAE Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 185. UAE Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Live Cell Imaging Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Live Cell Imaging Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Live Cell Imaging Market Share (%), By Products and Services, 2017-2031F
  • Figure 190. South Africa Live Cell Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 191. South Africa Live Cell Imaging Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Live Cell Imaging Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Products and Services Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023